Request Deal Involvement
Inflexion completed the acquisition of Rosemont Pharmaceuticals from Perrigo for $195m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Rothschild & Co
legal advisors
Trowers & Hamlins
accounting advisors
Grant Thornton
financial advisors
Deloitte
pr advisors
Citigate Dewe Rogerson
legal advisors
Travers Smith
legal advisors
Macfarlanes
or
Principals
bidder
INFLEXION PRIVATE EQUITY
target
ROSEMONT PHARMACEUTICALS
vendor
PERRIGO COMPANY PLC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite